Yusri Elsayed

4.0k citations
51 papers · 2.5k · 2 hit papers · h-index 23

Impact in

  • Oncology top 2%
    • CAR-T cell therapy research
  • Hematology top 2%
    • Multiple Myeloma Research and Treatments

Papers in

    • Cancer Treatment and Pharmacology 5
    • CAR-T cell therapy research 5
    • Colorectal Cancer Treatments and Studies 5
    • Multiple Myeloma Research and Treatments 9

Yusri Elsayed

50 papers receiving 2.4k citations

Yusri Elsayed's Hit Papers

Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer 2012 · 349 citations
3490+5+11Years since publication100200300400

Peers

Yusri Elsayed
Comparison fields: 5 of 87
  • Oncology 941
  • Hematology 374
  • Immunology 405
  • Pulmonary and Respiratory Medicine 527
  • Genetics 155
Replace Thomas A. Puchalski with:
Thomas A. Puchalski United States
Martin Steins Germany
Scott Cruickshank United States
Ali Amirkhosravi United States
Martin Schreder Germany
Yutaka Kawakami Japan
Wael A. Harb United States
Masashi Takeda Japan
Ashish M. Ingle United States
Leslie B. Lee United States
Yusri Elsayed relative to Thomas A. Puchalski United States Thomas A. Puchalski's profile →
Citations per field
00.5×1.5×
Thomas A. Puchalski · 1×
Citations per year

Countries citing papers authored by Yusri Elsayed

Since Specialization
Citations

This map shows the geographic impact of Yusri Elsayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusri Elsayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusri Elsayed more than expected).

Fields of papers citing papers by Yusri Elsayed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusri Elsayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusri Elsayed. The network helps show where Yusri Elsayed may publish in the future.

Co-authors

The 25 scholars most cited alongside Yusri Elsayed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yusri Elsayed Line = papers co-authored together Yusri Elsayed links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules
Hit paper breakdown →
2009410
2 2005361
3
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
Hit paper breakdown →
2012349
4 2020124
5 2009117
6 2013103
7 2005100
8 202095
9 201189
10 200379
11 200864
12 201653
13 200147
14 200940
15 202039
16 201137
17 202037
18 199635
19 199634
20 200733

About Yusri Elsayed

Yusri Elsayed is a scholar working on Oncology, Hematology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 51 papers that have together received 2.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (11 papers), Multiple Myeloma Research and Treatments (9 papers), Sarcoma Diagnosis and Treatment (5 papers), Cancer Treatment and Pharmacology (5 papers), CAR-T cell therapy research (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Histone Deacetylase Inhibitors Research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (941 citations), Hematology (374 citations), Immunology (405 citations), Pulmonary and Respiratory Medicine (527 citations) and Genetics (155 citations). Yusri Elsayed has collaborated with scholars based in United States, Belgium and France. Frequent co-authors include Edward A. Sausville, Manish Monga, Margaret von Mehren, Claudia Lebedinsky, Jean‐Yves Blay, Johann S. de Bono, Brian L. Samuels, Axel Le Cesne, Scott M. Schuetze and Miguel Izquierdo. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer Research, Blood Advances and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact